Clinical Trial Update: A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease [Phase 1]

View source ↗

Summary

Phase 1 trial update for LY2886721 in healthy participants and individuals with Alzheimer disease; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LY2886721

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alzheimer Disease, Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2019-07-19